Estimates of HIV testing at visits to United States emergency departments

被引:4
作者
Clay, Carson E. [1 ,2 ]
Hoover, Karen W. [3 ]
Le Guen, Yann [4 ]
Bennett, Christopher L. [2 ]
机构
[1] NYU, Grossman Sch Med, New York, NY USA
[2] Stanford Univ, Sch Med, Dept Emergency Med, Palo Alto, CA USA
[3] CDCP, Div HIV Prevent, Atlanta, GA USA
[4] Stanford Univ, Sch Med, Quantitat Sci Unit, Palo Alto, CA USA
关键词
emergency department screening; HIV screening; public health;
D O I
10.1097/QAD.0000000000003750
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: Emergency department-based HIV testing rates are historically low, but recent testing trends surrounding the COVID-19 pandemic and launch of the Ending the HIV Epidemic (EHE) initiative are unknown. The objective of the study is to estimate recent trends in the proportion of emergency department visits that included HIV testing. Methods: We performed a cross-sectional analysis of the National Hospital Ambulatory Medical Care Survey (NHAMCS), a weighted nationally representative survey of US emergency departments, from 2014 to 2020. Given EHE's focus on several rural Southern jurisdictions as well as populations disproportionately affected by HIV, we stratified by characteristics including US region and visit-listed race and ethnicity. Results: The proportion of emergency department visits that included HIV testing increased from 2014 (0.6%) to 2018 (1.1%) but was lower in 2019 and 2020 (0.8%). Compared with other regions, the South had the lowest rates of testing in both 2019 (0.6%) and 2020 (0.5%); testing rates in the nonmetropolitan South remained 0.1% or less across all years. Testing rates for emergency department visits by persons who identified as Hispanic/Latino were highest in 2018 (2.2%) but were sharply lower in 2019 and 2020 (0.8%). Conclusion: After a small but insufficient increase in emergency department-based HIV testing since 2014, rates decreased between 2018 and 2019 and were stable between 2019 and 2020. Overall, very few emergency department visits during our entire study period included an HIV test, and there were persistently low rates of HIV testing for populations prioritized in national efforts and during visits in rural jurisdictions in the South. Copyright (C) 2023 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码:255 / 259
页数:5
相关论文
共 12 条
[1]  
[Anonymous], 2007, HIV TESTING
[2]  
[Anonymous], Ending the HIV Epidemic: A plan for America
[3]   Characteristics of US Emergency Departments That Offer Routine Human Immunodeficiency Virus Screening [J].
Berg, Laura J. ;
Delgado, M. Kit ;
Ginde, Adit A. ;
Montoy, Juan Carlos ;
Bendavid, Eran ;
Camargo, Carlos A., Jr. .
ACADEMIC EMERGENCY MEDICINE, 2012, 19 (08) :894-900
[4]   HIV Testing at Visits to US Emergency Departments, 2018 [J].
Clay, Carson E. ;
Ling, Albee Y. ;
Bennett, Christopher L. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2022, 90 (03) :256-262
[5]   Persistent Postconcussion Symptoms After Injury [J].
Ewing-Cobbs, Linda ;
Cox, Charles S. ;
Clark, Amy E. ;
Holubkov, Richard ;
Keenan, Heather T. .
PEDIATRICS, 2018, 142 (05)
[6]   Trends in Emergency Department Use by Rural and Urban Populations in the United States [J].
Greenwood-Ericksen, Margaret B. ;
Kocher, Keith .
JAMA NETWORK OPEN, 2019, 2 (04) :e191919
[7]   Impact of the COVID-19 Pandemic on Emergency Department Visits-United States, January 1, 2019-May 30, 2020 [J].
Hartnett, Kathleen P. ;
Kite-Powell, Aaron ;
DeVies, Jourdan ;
Coletta, Michael A. ;
Boehmer, Tegan K. ;
Adjemian, Jennifer ;
Gundlapalli, Adi, V .
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 69 (23) :699-704
[8]  
Hoover KW, 2022, MMWR-MORBID MORTAL W, V71, P1505, DOI 10.15585/mmwr.mm7148a1
[9]   HIV Testing Trends at Visits to Physician Offices, Community Health Centers, and Emergency Departments - United States, 2009-2017 [J].
Hoover, Karen W. ;
Huang, Ya-Lin A. ;
Tanner, Mary L. ;
Zhu, Weiming ;
Gathua, Naomie W. ;
Pitasi, Marc A. ;
Dinenno, Elizabeth A. ;
Nair, Suma ;
Delaney, Kevin P. .
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 69 (25) :776-780
[10]  
Kelen GD., 2021, NEJM CATALYST, V2